AbbVie and Johnson and Johnson both trade near 52-week highs and carry decades of dividend raises, but one faces a patent cliff and a leveraged balance sheet that could force retirees to rethink their…
A $15,000 bet split across three Nasdaq giants could look very different by 2030 depending on which of them ends up dragging the whole portfolio down.
Ryan Cohen just put $26 million of his own money into GameStop shares, yet the stock is sliding hard anyway. The question now is whether that insider conviction holds the monthly rally together or…
Merger filings from one of Hollywood's biggest consolidations tell a very different story about job losses than the one studio executives keep repeating in public. The real culprits are hiding in the debt schedules…
Jaguar Health is surging on a float so thin that a handful of trades can swing the price wildly, while a rare pediatric disease program edges closer to a pivotal regulatory filing that could…
Defense budgets are soaring on both sides of the Atlantic, and one ETF promises to capture the entire boom in a single trade. But a closer look at what you actually own when you…
Lisa Su's latest earnings call left me convinced the market still has not priced what AMD is actually building, and I added to my position again this week to get ahead of the milestone…
Beef is bleeding hundreds of millions in losses while Tyson's stock slides, yet the company keeps writing dividend checks without flinching. Whether that confidence is earned or reckless depends on what you look at…
Meta Platforms is sliding after a stunning one-month run, but the real question is whether its new AI agent Muse can actually deliver the revenue that fueled the rally or leave investors holding an…
Wall Street analysts see 40% upside in Micron, yet the stock just dropped sharply after a blowout earnings beat. Something underneath the headline numbers explains why the bull case may be stronger now than…
NVIDIA trades at a multiple more typical of a mature chipmaker than a company growing revenue north of 100% year over year, and that gap between perception and reality is exactly where the next…
Philip Morris and Altria both just raised their dividends, but the gap between them runs far deeper than yield percentages and payout sizes. Which tobacco giant actually deserves a spot in a retirement portfolio…
With the stock market leaning hard on one shaky pillar and U.S. debt crossing $40 trillion, a 57-year-old dividend stalwart from an industry everyone loves to hate might be the safest place to park…
HSBC just flipped its rating on Synopsys with a price target that towers above Wall Street consensus, and the reasoning behind it reframes the chip design giant as something the market may not have…
Berkshire Hathaway has gone nowhere for a year while the S&P 500 climbed 12.5%, and the reasons behind that divergence reveal a company in the middle of a transformation that could resolve as either…
